AU2003289876A8 - Cutaneous application of flupirtine - Google Patents

Cutaneous application of flupirtine

Info

Publication number
AU2003289876A8
AU2003289876A8 AU2003289876A AU2003289876A AU2003289876A8 AU 2003289876 A8 AU2003289876 A8 AU 2003289876A8 AU 2003289876 A AU2003289876 A AU 2003289876A AU 2003289876 A AU2003289876 A AU 2003289876A AU 2003289876 A8 AU2003289876 A8 AU 2003289876A8
Authority
AU
Australia
Prior art keywords
flupirtine
cutaneous application
cutaneous
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003289876A
Other versions
AU2003289876A1 (en
Inventor
Dirk Mertin
Sabine Becker
Gerald Beddies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003289876A8 publication Critical patent/AU2003289876A8/en
Publication of AU2003289876A1 publication Critical patent/AU2003289876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003289876A 2002-11-28 2003-11-18 Cutaneous application of flupirtine Abandoned AU2003289876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10255415A DE10255415A1 (en) 2002-11-28 2002-11-28 Dermal application of flupirtine
DE10255415.3 2002-11-28
PCT/EP2003/012875 WO2004047795A2 (en) 2002-11-28 2003-11-18 Cutaneous application of flupirtine

Publications (2)

Publication Number Publication Date
AU2003289876A8 true AU2003289876A8 (en) 2004-06-18
AU2003289876A1 AU2003289876A1 (en) 2004-06-18

Family

ID=32308774

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003289876A Abandoned AU2003289876A1 (en) 2002-11-28 2003-11-18 Cutaneous application of flupirtine

Country Status (3)

Country Link
AU (1) AU2003289876A1 (en)
DE (1) DE10255415A1 (en)
WO (1) WO2004047795A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (en) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Medicinal products for topical application in animals
DE102007034976A1 (en) * 2007-07-26 2009-01-29 Bayer Healthcare Ag Medicinal products for transdermal use in animals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601195A1 (en) * 1985-01-23 1986-07-24 Degussa Ag, 6000 Frankfurt Synergistic combination of flupirtine and non-steroidal antiinflammatory drugs
IN172468B (en) * 1990-07-14 1993-08-14 Asta Medica Ag

Also Published As

Publication number Publication date
WO2004047795A2 (en) 2004-06-10
DE10255415A1 (en) 2004-06-09
AU2003289876A1 (en) 2004-06-18
WO2004047795A3 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2002303927A1 (en) Methods and apparatuses to identify devices
AU2003224638A8 (en) Pdpk1s as modifiers of the p53 pathway and methods of use
HK1077762A1 (en) INHIBITORS OF TFGβ
AU2003236991A8 (en) Representations of processes
EP1511488A4 (en) Human adam-10 inhibitors
AU2003279841A1 (en) Uses of human zven antagonists
AU2003260778A1 (en) Treatment of pipes
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
EP1545287A4 (en) Vasoregulating compounds and methods of their use
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2003289876A8 (en) Cutaneous application of flupirtine
AU2003298725A8 (en) Preparation of metallotexaphyrins
AU2003239279A1 (en) Laryngotracheal devices and methods of use thereof
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003274359A1 (en) Treatment of fluids
PL356853A1 (en) Application of bacteriphages
AU2003213665A1 (en) Lgals as modifiers of the chk pathway and methods of use
AU2003213693A1 (en) MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
AU2003303094A8 (en) Mat2as as modifiers of the p53 pathway and methods of use
AU2003219825A1 (en) Devices and method of manufacture
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase